Abstract:The purpose of this work was to compare the clinical characteristics, rate of recurrent venous thromboembolism (VTE), bleeding complications and mortality of incidental and symptomatic pulmonary embolism (PE) detected on computed tomography in patients with lung cancer. Clinical data of lung cancer patients with PE were obtained from the Department of Respiratory and Critical Care Medicine of Ningbo First affiliated hospital of Ningbo University during January 2016 and June 2021 and were reviewed retrospectively. We compared clinical and radiological characteristics in lung cancer patients with incidental PE (IPE) and symptomatic PE (SPE) and identified variables associated with the 1-year survival on multivariate Cox analysis. All patients were followed up for 1 year to compare the risks of recurrent VTE, bleeding complications, and mortality. Survival analysis was performed by use of Kaplan-Meier. A total of 223 lung cancer patients with PE were enrolled over the period. Of these, 117 (52%) patients had symptomatic whereas 106 (48%) patients had incidental PE. Those with IPE were more likely to have adenocarcinoma, VTE history, chronic respiratory disease and chemotherapy within 30 days prior to PE, while SPE was more frequently observed in patients with squamous cancer, concomitant VTE, performance status 0-1, chronic heart disease and major surgery within 30 days prior to PE. During 1 year of follow-up, recurrent VTE was diagnosed in 10 patients (9.3%) in lung cancer patients with IPE and 13 patients (11.2%) with SPE. The 12-month cumulative recurrent VTE incidence was 9.6% for patients with incidental and 11.4% for patients with symptomatic PE (P = .61). The 12-month cumulative incidences of major bleeding complications were also comparable in the 2 groups (8.1% for incidental patients and 9.8% for symptomatic patients; P = .62). However, the respective 12-month mortality risks were 34.6% and 30.2% in lung cancer patients with IPE and SPE respectively (P = .03). On multivariate Cox analysis, we found that IPE occurrence was an independent risk factor associated with 1-year mortality in lung cancer patients complicated with PE after adjusting for age and sex (HR 1.517; 95% CI: 1.366-1.684; P = .027). Our findings suggest that lung cancer patients diagnosed with and treated for incidental PE had a similar rate of recurrent VTE, and incidence of hemorrhagic complications, but a significantly higher 1-year cumulative mortality rate after PE compared to those with symptomatic PE. IPE may be a marker of poor prognosis.

Abstract No. 485 Clinical and Radiographic Determinants of Survival in Cancer Patients with Acute Pulmonary Embolus

Incidentally Diagnosed with Pulmonary Embolism in Lung Cancer Patients: Comparison of Clinical Characteristics and Mortality with Symptomatic Pulmonary Embolism

Characteristics and 6-Month Mortality of Medical Oncology Patients with Incidental and Symptomatic Pulmonary Embolism: A Single-Institutional Retrospective Longitudinal Analysis.

[The Impact of Right Ventricular Dysfunction on the Clinical Outcome of Normotensive Patients with Pulmonary Embolism].

Clinical analysis of acute pulmonary embolism in 49 cases

A Multimodality Imaging Approach to Defining Risk in Patients With Acute Pulmonary Embolism

The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism

Quantitative volumetric computed tomography embolic analysis, the Qanadli score, biomarkers, and clinical prognosis in patients with acute pulmonary embolism

Prognostic Role of Serial Electrocardiographic Changes in Patients with Acute Pulmonary Embolism. Data from the Italian Pulmonary Embolism Registry

Disparities in the Outcomes of Acute Pulmonary Embolism in Hospitalized Patients with Hematologic Malignancy and Solid Tumor.

Clinical Analysis of 106 Cases Pulmonary Embolism

Short-term Outcome of Patients with History of Significant Coronary Artery Disease Following Acute Pulmonary Embolism

Predictors of mid-term prognosis and adverse factors in acute pulmonary embolism.

Intensify Standardized Anticoagulation for Cancer-Associated Pulmonary Embolism: From Single-Center Real-World Data

Impact of Clinical Profile at Admission on the Outcomes in Patients Hospitalized for Acute Pulmonary Embolism: Data from the IPER Registry

Saddle Pulmonary Embolism: Laboratory and Computed Tomographic Pulmonary Angiographic Findings to Predict Short-term Mortality

Treatment of Pulmonary Embolism:An Analysis of 128 Cases

TIMI Risk Index As a Predictor of 30-Day Outcomes in Patients with Acute Pulmonary Embolism.

Outcomes of acute pulmonary embolism in hospitalized patients with cancer

[Clinical Analysis of 23 Lung Cancer Patients Accompanied by Pulmonary Embolism].

Risk Stratification and Management of Intermediate-Risk Acute Pulmonary Embolism